These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19888632)

  • 1. Caution in adding bevacizumab in the adjuvant treatment of breast cancer.
    Ziogas D; Roukos D
    Ann Surg Oncol; 2010 Feb; 17(2):653-4; author reply 655-6. PubMed ID: 19888632
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of bevacizumab in mild haemophilia B.
    Lambert C; Deneys V; Pothen D; Hermans C
    Thromb Haemost; 2008 May; 99(5):963-4. PubMed ID: 18449429
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission of psoriasis following bevacizumab therapy for colon cancer.
    Akman A; Yilmaz E; Mutlu H; Ozdogan M
    Clin Exp Dermatol; 2009 Jul; 34(5):e202-4. PubMed ID: 19077094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions.
    Ocaña A; Amir E; Vera F; Eisenhauer EA; Tannock IF
    J Clin Oncol; 2011 Jan; 29(3):254-6. PubMed ID: 21149670
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiangiogenic agents in breast cancer.
    Salter JT; Miller KD
    Cancer Invest; 2007 Oct; 25(7):518-26. PubMed ID: 18027149
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed news for Avastin.
    Mack GS
    Nat Biotechnol; 2009 Jun; 27(6):494. PubMed ID: 19513035
    [No Abstract]   [Full Text] [Related]  

  • 7. Accrual delayed in adjuvant bevacizumab trial.
    Tuma RS
    J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's disease.
    Coriat R; Mir O; Leblanc S; Ropert S; Brezault C; Chaussade S; Goldwasser F
    Inflamm Bowel Dis; 2011 Jul; 17(7):1632. PubMed ID: 21674721
    [No Abstract]   [Full Text] [Related]  

  • 9. Bevacizumab in the treatment of colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver resection after FOLFOX with bevacizumab.
    Mickle M; Mulcahy MF
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
    [No Abstract]   [Full Text] [Related]  

  • 11. In focus: non-small cell lung cancer: E1505.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):206-8. PubMed ID: 17519882
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted agents for adjuvant therapy of colon cancer.
    Saif MW
    Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy a two-trick pony?
    Hampton T
    JAMA; 2005 Mar; 293(9):1051. PubMed ID: 15741519
    [No Abstract]   [Full Text] [Related]  

  • 14. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of VEGF inhibitors and anti-oestrogen therapies in breast cancer.
    Banerjee S
    Steroids; 2011 Jul; 76(8):807-11. PubMed ID: 21439993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The safety of perioperative bevacizumab use].
    Mariani P
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular target therapy for colonic neoplasms].
    Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab in breast cancer: the best is yet to come?
    Puhalla S; Brufsky A
    Oncology (Williston Park); 2009 Apr; 23(4):332, 335. PubMed ID: 19476262
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.
    Marty M; Pivot X
    Eur J Cancer; 2008 May; 44(7):912-20. PubMed ID: 18396037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy of colon cancer].
    Seufferlein T; V Wichert G; Adler G
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1951-62. PubMed ID: 17853351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.